Bespoke Extracts (BSPK) Net Cash Flow Growth (3y) (2014 - 2025)
Bespoke Extracts (BSPK) Net Cash Flow Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -49.94% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -62.71% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 26.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 26.68% |
| Jun 30, 2025 | -27.57% |
| Mar 31, 2025 | 17.79% |
| Nov 30, 2021 | -28.90% |
| Aug 31, 2021 | 24.78% |
| May 31, 2021 | -89.25% |
| Feb 28, 2021 | 313.20% |
| Nov 30, 2020 | 40.49% |
| May 31, 2020 | -31.91% |
| Feb 29, 2020 | -72.96% |
| Nov 30, 2019 | 71.99% |
| Aug 31, 2019 | -107.14% |
| May 31, 2019 | 28.14% |
| Feb 28, 2019 | 64.29% |
| Nov 30, 2018 | 36.87% |
| Aug 31, 2018 | -67.04% |
| May 31, 2018 | 53.59% |
| Feb 28, 2018 | 26.75% |
| Nov 30, 2017 | 42.89% |
| Aug 31, 2017 | 1.98% |